Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

807
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
807
Life Tables01:22

Life Tables

693
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
693
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

503
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
503
Censoring Survival Data01:09

Censoring Survival Data

706
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
706
Actuarial Approach01:20

Actuarial Approach

396
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
396
Applications of Life Tables01:22

Applications of Life Tables

439
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
439

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same author

High-Risk Substance and Polysubstance Use Among Elective Surgery Patients: Prevalence and Risk Factors.

Journal of the American College of Surgeons·2026
Same author

Adaptive intervention strategies for malaria vector control in western Kenya: a cluster, sequential, multiple-assignment, randomised, open-label trial.

The Lancet. Global health·2026
Same author

Feasibility Pilot Trial for the Trajectories of Recovery after Intravenous Propofol versus Inhaled Volatile Anesthesia (THRIVE) Pragmatic Randomized Clinical Trial.

Anesthesiology·2026
Same author

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

JAMA otolaryngology-- head & neck surgery·2025
Same author

SMARTs with treatment preference: Pragmatic SMART design and methods motivated by STAR*D.

Contemporary clinical trials·2025

Related Experiment Video

Updated: May 5, 2026

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan
11:58

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan

Published on: June 29, 2018

9.4K

Inference for the median residual life function in sequential multiple assignment randomized trials.

Kelley M Kidwell1, Jin H Ko, Abdus S Wahed

  • 1Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, U.S.A.

Statistics in Medicine
|November 21, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to estimate median residual life (MERL) for dynamic treatment regimens in sequential trials. The proposed estimator and its variance estimates are shown to be unbiased in simulations.

Keywords:
adaptive treatment strategydynamic treatment regimeninverse probability weightingmedian residual life functionnon-parametric estimationsequential randomization

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

34.2K

Related Experiment Videos

Last Updated: May 5, 2026

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan
11:58

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan

Published on: June 29, 2018

9.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

34.2K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Survival Analysis

Background:

  • Median residual lifetime is a key metric for assessing treatment effectiveness in survival analysis.
  • Estimating this metric for dynamic treatment regimens in sequential trials presents methodological challenges.

Purpose of the Study:

  • To propose and evaluate a novel method for estimating the dynamic treatment regimen-specific median residual life (MERL) function.
  • To develop and assess variance estimators for the proposed MERL estimator.

Main Methods:

  • Developed a MERL estimator using inverse probability weighting.
  • Incorporated two variance estimation strategies: a survival function-based estimate and a sandwich estimator.
  • Evaluated estimator performance and variance estimates through simulation studies.

Main Results:

  • The MERL estimator and both variance estimates demonstrated approximate unbiasedness in large sample simulations.
  • The proposed method was successfully applied to a real-world sequentially randomized leukemia clinical trial.

Conclusions:

  • The developed MERL estimator provides a viable approach for assessing dynamic treatment effectiveness in sequential trials.
  • The proposed variance estimators are reliable for quantifying uncertainty in MERL estimates.